Literature DB >> 33683981

Posterior Blepharitis and Associated Potential Factors: A Study among Pregnant Women.

Samuel Kyei1, Kofi Asiedu2,3, Richard K D Ephraim4, Madison Adanusa5.   

Abstract

Purpose: This study evaluates in a cross-section of pregnant women the frequency of posterior blepharitis, its predisposing factors and how lipid profile impacts the occurrence of posterior blepharitis in pregnancy.
Methods: This was a hospital-based cross-sectional study of pregnant women.
Results: In this study, 201 pregnant women were recruited and included in the study's analysis. The participants' mean age was 29.96 (±4.74) years, with a median age of 30 and a range of 17 to 40 years. The frequency of posterior blepharitis among this cohort was 13.4% (95% confidence interval, 9.0% to 18.4%). The frequencies of MGD-associated posterior blepharitis and non-MGD associated posterior blepharitis were 6.0% and 7.4%, respectively. There was no statistically significant difference in the mean fluorescein tear breakup time and SPEED scores between non-MGD associated posterior blepharitis and MGD-associated posterior blepharitis, however, the mean tear breakup time(t = 3.999, p < .001) and SPEED scores (t = 6.76, p < .0001) showed a statistically significant difference in posterior blepharitis pregnant women compared to non-posterior blepharitis pregnant women. There was a statistically significant difference in the mean corneal staining scores between non-MGD-associated posterior blepharitis and MGD-associated posterior blepharitis (t = 3.99, p = .001). There was no association between lipid profile and posterior blepharitis in binary logistic regression analysis
Conclusion: The study showed that posterior blepharitis occurs in pregnancy, but it is not associated with cholesterol levels.

Entities:  

Keywords:  Lid margin; inflammation; meibomian glands; ocular surface; telangiectasia

Year:  2021        PMID: 33683981     DOI: 10.1080/09273948.2021.1896007

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  4 in total

1.  Improved Watershed Algorithm-Based Microscopic Images Combined with Meibomian Gland Microprobe in the Treatment of Demodectic Blepharitis.

Authors:  Lanying Liu; Shengfu Yang; Min Zhu; Min Wang; Xin Wei
Journal:  Comput Math Methods Med       Date:  2022-06-08       Impact factor: 2.809

2.  Bevacizumab Eye Drops Vs. Intra-meibomian Gland Injection of Bevacizumab for Meibomian Gland Dysfunction-Associated Posterior Blepharitis.

Authors:  Chitchanok Tantipat; Ngamjit Kasetsuwan; Patraramon Chotikkakamthorn; Krit Pongpirul
Journal:  Front Med (Lausanne)       Date:  2022-06-10

Review 3.  Candidate Molecular Compounds as Potential Indicators for Meibomian Gland Dysfunction.

Authors:  Kofi Asiedu
Journal:  Front Med (Lausanne)       Date:  2022-05-24

4.  Impact of meibomian gland dysfunction on quality of life and mental health in a clinical sample in Ghana: a cross-sectional study.

Authors:  Kofi Asiedu; Selassie Dzasimatu; Samuel Kyei
Journal:  BMJ Open       Date:  2022-09-30       Impact factor: 3.006

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.